Eur J Orthod. 2023 Jul 19:cjad029. doi: 10.1093/ejo/cjad029. Online ahead of print.
ABSTRACT
BACKGROUND: During orthodontic therapy, bond failure of molar tubes may delay treatment. With the high failure rate of molar tubes, alternative bonding techniques were tested to improve bond strength.
OBJECTIVES: To compare the failure rates of molar tubes bonded with conventional and alternative bonding techniques by adding a layer of compomer adhesive at the molar/tube interface.
TRIAL DESIGN: Single-centre, single-blinded, split-mouth, randomized clinical trial.
METHODS: Patients aged 12 years or older, who required fixed appliance orthodontic treatment without extraction and with no occlusal interference were eligible to participate. They were allocated randomly using a simple non-stratified split-mouth design with a 1:1 allocation ratio. Blinding was only possible for the patients and data analysts. Molar tubes bonded with the modified bonding technique had an additional layer of compomer at the occlusal molar/tube interface. The patients were followed-up for nine months. Outcome measures included the survival time of molar tubes and the number of molar tubes debonded. The bond failure of molar tubes was analyzed using Kaplan-Meier and Cox regression analysis (P < 0.05).
RESULTS: Thirty patients were recruited, randomized, and analyzed (mean age 20.33 years). The failure rate of molar tubes bonded with the modified bonding technique was 4.2 per cent and that of molar tubes bonded with the conventional bonding technique was 6.7 per cent. This difference was not statistically significant (P > 0.05). The dental arch and molar type were found to be as significant predictors for molar tube failure rate. No harm was detected during treatment.
LIMITATIONS: The effect of compomer to reduce enamel demineralization was not tested.
CONCLUSIONS AND IMPLICATIONS: The modified bonding technique did not significantly reduce the failure rate of molar tubes. The molar tubes bonded on the upper arch and second molars are more susceptible to debond.
REGISTRATION: The trial was registered with ClinicalTrials.gov on 21 May 2022 (Registration number: NCT05391386).
FUNDING: This research did not receive any funding.
PMID:37467348 | DOI:10.1093/ejo/cjad029
